MedPath

Maestro Agreement and Precision Study II

Completed
Conditions
Normal Healthy Subjects With No Known Ocular Diseases
Eyes With Retinal Diseases
Glaucomatous Eyes
Interventions
Device: 3D OCT-1 Maestro
Device: iVue
Registration Number
NCT02376868
Lead Sponsor
Topcon Medical Systems, Inc.
Brief Summary

Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, Full Retinal Thickness, and Ganglion Cell Thickness between the Maestro and iVue OCT devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Glaucomatous Eyes3D OCT-1 MaestroSubjects presenting with different stages of glaucoma will be scanned with the iVue and Maestro device
Glaucomatous EyesiVueSubjects presenting with different stages of glaucoma will be scanned with the iVue and Maestro device
Eyes with Retinal DiseasesiVueSubjects presenting with Retinal pathological eyes will be scanned on the iVue and Maestro device
Normal Eyes3D OCT-1 MaestroSubjects with no known ocular diseases will be scanned with the iVue and Maestro device
Eyes with Retinal Diseases3D OCT-1 MaestroSubjects presenting with Retinal pathological eyes will be scanned on the iVue and Maestro device
Normal EyesiVueSubjects with no known ocular diseases will be scanned with the iVue and Maestro device
Primary Outcome Measures
NameTimeMethod
Optic Disc Measurements (Optic Disc/Cup Size)1 Hour

Reporting of the Optic Disc Size and Cup Size

Retinal Nerve Fiber Layer (RNFL) Thickness Measurements At Different Clock Hours1 Hour

RNFL thickness measured at different clock hours

Full Retinal Thickness Measurements1 Hour

Full Retinal Thicknesses measured in different quadrants of the scan

Ganglion Cell Thickness Measurements1 Hour

Ganglion Cell Thickness measured in different quadrants of the scan

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Western University of Health Sciences

🇺🇸

Pomona, California, United States

© Copyright 2025. All Rights Reserved by MedPath